Novo Nordisk wins blocking order in UK to combat counterfeit drugs
By Douglas Clarke-Williams ( June 12, 2026, 13:54 GMT | Insight) -- Novo Nordisk can legally block more than 130 websites selling counterfeit versions of its blockbuster weight loss drug, along with other illicit medical devices, a UK judge ruled Friday. The company was also granted the ability to institute accelerated orders against any similar websites which infringe the company’s intellectual property in the same way.Novo Nordisk gained permission from a UK judge on Friday to block more than 130 websites selling counterfeit versions of the company's popular semaglutide weight loss medication and misusing the Danish company’s branding....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.